###begin article-title 0
###xml 41 42 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Kindlin-2 (Mig-2): a co-activator of beta3 integrins
###end article-title 0
###begin p 1
###xml 34 47 34 47 <email xmlns:xlink="http://www.w3.org/1999/xlink">plowe@ccf.org</email>
Correspondence to Edward F. Plow: plowe@ccf.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 351 352 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 368 371 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 469 470 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 501 504 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 521 524 512 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 752 755 739 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 759 760 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 853 856 833 836 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 860 861 837 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 914 915 887 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 919 920 889 890 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Integrin activation is essential for dynamically linking the extracellular environment and cytoskeletal/signaling networks. Activation is controlled by integrins' short cytoplasmic tails (CTs). It is widely accepted that the head domain of talin (talin-H) can mediate integrin activation by binding to two sites in integrin beta's CT; in integrin beta3 this is an NPLY747 motif and the membrane-proximal region. Here, we show that the C-terminal region of integrin beta3 CT, composed of a conserved TS752T region and NITY759 motif, supports integrin activation by binding to a cytosolic binding partner, kindlin-2, a widely distributed PTB domain protein. Co-transfection of kindlin-2 with talin-H results in a synergistic enhancement of integrin alphaIIbbeta3 activation. Furthermore, siRNA knockdown of endogenous kindlin-2 impairs talin-induced alphaIIbbeta3 activation in transfected CHO cells and blunts alphavbeta3-mediated adhesion and migration of endothelial cells. Our results thus identify kindlin-2 as a novel regulator of integrin activation; it functions as a coactivator.
###end p 3
###begin p 4
###xml 63 68 <span type="species:ncbi:9606">human</span>
Abbreviations used in this paper: CT, cytoplasmic tail; HUVEC, human umbilical vein endothelial cell; talin-H, talin head domain.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 236 247 236 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Hynes, 2002</xref>
###xml 333 349 333 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Qin et al., 2004</xref>
###xml 351 366 351 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Ma et al., 2007</xref>
###xml 425 426 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 538 539 532 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 692 716 678 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Vinogradova et al., 2002</xref>
###xml 789 808 775 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Hughes et al., 1996</xref>
###xml 810 826 796 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Kim et al., 2003</xref>
###xml 828 843 814 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Ma et al., 2006</xref>
###xml 884 885 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 924 927 907 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 936 939 919 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 1010 1013 993 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 1023 1031 1006 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 1086 1089 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 1109 1110 1092 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1255 1279 1238 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Vinogradova et al., 2002</xref>
###xml 1281 1302 1264 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Tadokoro et al., 2003</xref>
###xml 1304 1324 1287 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Wegener et al., 2007</xref>
###xml 1405 1422 1388 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Chen et al., 1994</xref>
###xml 1424 1444 1407 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">O'Toole et al., 1995</xref>
###xml 1446 1461 1429 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Xi et al., 2003</xref>
###xml 1463 1478 1446 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Ma et al., 2006</xref>
###xml 1667 1668 1647 1648 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1681 1684 1661 1664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 1694 1697 1674 1677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
Integrin activation, the rapid transition from a low to a high affinity state for ligand, regulates the numerous cellular responses consequent to integrin engagement by extracellular matrix proteins or counter-receptors on other cells (Hynes, 2002). This transformation is tightly controlled by the integrin cytoplasmic tails (CTs) (Qin et al., 2004; Ma et al., 2007). Mutational and structural analyses suggest that the beta3 CT can be divided two regions, and both influence integrin activation. The membrane-proximal region of the beta3 CT is primarily alpha-helix, which interacts with the membrane-proximal helix of the alpha subunit through several electrostatic and hydrophobic bonds (Vinogradova et al., 2002). Unclasping of the complex is a critical event in integrin activation (Hughes et al., 1996; Kim et al., 2003; Ma et al., 2006). The membrane-distal region of the beta3 CT contains two NXXY turn motifs, NPLY747 and NITY759, which are separated by a short helix containing a T/S cluster, the TS752T region (Fig. 1 A). The head domain of talin (talin-H) docks at the NPLY747 motif through its F3 domain and also interacts with the membrane-proximal region, perturbing the membrane clasp and leading to at least partial integrin activation (Vinogradova et al., 2002; Tadokoro et al., 2003; Wegener et al., 2007). The T/S cluster and the NITY motif are also critical for integrin activation (Chen et al., 1994; O'Toole et al., 1995; Xi et al., 2003; Ma et al., 2006). However, the mechanisms underlying their effects remain unresolved. In this study, we found that kindlin-2, a widely distributed PTB domain protein, interacts with the C terminus of beta3 CT at the TS752T and NITY759 motifs and markedly enhances talin-induced integrin activation. Thus, kindlin-2 is identified as a coactivator of integrins.
###end p 6
###begin p 7
###xml 47 48 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 90 93 83 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 97 98 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 110 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequences of the membrane-distal region of &#946;<sub>3</sub> CT have essential roles in integrin &#945;<sub>IIb</sub>&#946;<sub>3</sub> activation.</bold>
###xml 274 277 257 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 281 282 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 324 325 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 461 462 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 490 491 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 525 528 492 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 532 533 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 788 791 747 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 795 796 751 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 832 835 784 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 844 845 793 794 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 964 967 909 912 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 971 972 913 914 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1007 1010 945 948 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 1014 1015 949 950 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1218 1233 1153 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Ma et al., 2006</xref>
Sequences of the membrane-distal region of beta3 CT have essential roles in integrin alphaIIbbeta3 activation. (A) Alignment of integrin beta CT sequences, highlighting (red) the conserved regions, the two NXXY/F motifs and one T/S cluster. (B) Suppression of integrin alphaIIbbeta3-mediated cell spreading by expressed beta3 CT depends on conserved sequences in its membrane-distal region. After transient transfection with plasmids encoding the indicated beta3 CT-containing chimera (beta3 CT/PSGL-1), adhesion of the alphaIIbbeta3-CHO cells to fibrinogen was examined. The adherent cells were fixed and stained with the anti-PSGL-1 mAb, KPL-1, for visualization by fluorescence microscopy (10x objective). Bar, 20 mum. (C) Conserved residues in the membrane-distal region support alphaIIbbeta3 activation. Plasmids encoding alphaIIb and beta3 or its mutants were transiently transfected to CHO cells. The transfected cells were stained with 2G12 to assess alphaIIbbeta3 expression or PAC1 to assess alphaIIbbeta3 activation. FACS was used to measure the mean fluorescence intensity (MFI) of 2G12 or PAC1 binding, and relative MFI of PAC1 binding was normalized to integrin expression levels based on 2G12 staining (Ma et al., 2006). The error bars represent means +/- SD of three independent experiments.
###end p 7
###begin title 8
Results and discussion
###end title 8
###begin p 9
###xml 80 81 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 198 201 191 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 205 206 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 272 273 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 495 515 479 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Fenczik et al., 1997</xref>
###xml 544 545 525 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 678 679 656 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 816 817 791 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 829 832 800 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 836 837 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 981 982 946 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1016 1019 977 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 1023 1024 981 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1050 1058 1008 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1088 1091 1046 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 1241 1242 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1256 1259 1211 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 1266 1269 1221 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 1490 1493 1445 1448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 1497 1500 1452 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 1507 1510 1462 1465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
To address the functional significance of the membrane-distal region of the beta3 CT, we considered whether it might interact with intracellular regulator(s). A CHO cell line stably expressing alphaIIbbeta3 was transfected with cDNAs encoding for wild-type or mutated beta3 CT based on the rationale that these expressed constructs would compete for integrin binding partners. A similar strategy had been used previously to screen the beta CT binding partners essential for integrin activation (Fenczik et al., 1997). In our studies, these beta3 CT were expressed as chimeric constructs containing the extracellular domain of PSGL-1 so that expression levels of the various beta3 CT could be verified. As assessed by flow cytometry (FACS), PSGL-1 expression differed by less than 10%. The effects of the various beta3 CT on alphaIIbbeta3-mediated cell spreading on immobilized fibrinogen were evaluated. Compared with cells expressing PSGL-1 alone, expression of the wild-type beta3CT chimera totally abolished alphaIIbbeta3-mediated cell spreading (Fig. 1 B). As a specificity control, Y747A mutation, which would interfere with talin binding, resulted in a loss of inhibitory activity. Other mutations in the membrane-distal region in beta3 CT chimera, S752P and Y759A, beyond the talin interactive sites and which perturb key structural features in this region, the short helix and the turn motif, respectively, also led to loss of competitive activity. This loss was not observed with Y747F, S752A, or Y759F substitutions, which would sustain the secondary structural features of the membrane-distal region.
###end p 9
###begin p 10
###xml 142 145 138 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 149 150 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 183 186 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">995</sup>
###xml 196 199 185 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 204 207 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">723</sup>
###xml 216 218 202 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3,</sub>
###xml 259 262 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">995</sup>
###xml 268 271 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">723</sup>
###xml 408 427 394 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Hughes et al., 1996</xref>
###xml 429 450 415 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Tadokoro et al., 2003</xref>
###xml 452 467 438 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Ma et al., 2006</xref>
###xml 521 524 507 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 532 535 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 545 548 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 556 559 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 622 625 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">995</sup>
###xml 628 636 614 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 712 715 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 721 724 707 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 893 896 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 899 916 885 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Chen et al., 1992</xref>
###xml 918 922 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">1994</xref>
###xml 968 971 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 1014 1029 1000 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Ma et al., 2006</xref>
###xml 1110 1111 1093 1094 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1186 1194 1166 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
Cell spreading is a complex response and we sought to confirm the role of membrane-distal residues in integrin activation more directly. alphaIIbbeta3 containing a point mutation of R995D in alphaIIb or D723R in beta3, which disrupts a salt bridge formed by R995 and D723, is a particularly sensitive reporter of talin-H-induced activation in a CHO cell system as assessed with the ligand mimetic mAb, PAC1 (Hughes et al., 1996; Tadokoro et al., 2003; Ma et al., 2006). Disrupting either of the two NXXY turn motifs, NPLY747 or NITY759, with a Y747A or a Y759A mutation dramatically impairs integrin activation caused by R995D (Fig. 1 C). However, conservative substitutions that should be structurally silent, Y747F or Y759F, have no significant effect on integrin activation. Consistent with previous data, disruption of the short helix between two NXXY motifs with the naturally occurring S752P (Chen et al., 1992, 1994) suppresses integrin activation whereas the S752A substitution, which maintains the helix (Ma et al., 2006), does not affect activation. Although the above description focuses on the beta3 CT, most of the key sequences are shared by other integrin beta subunits (Fig. 1 A), and the potential to be activated extends to multiple integrin subfamilies.
###end p 10
###begin p 11
###xml 38 54 38 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 (B and C)</xref>
###xml 101 102 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 332 333 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 394 395 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 430 433 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 543 544 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 579 603 567 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Eigenthaler et al., 1997</xref>
###xml 605 623 593 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Kiema et al., 2006</xref>
###xml 744 745 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 821 824 799 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 828 829 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 935 950 910 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A and B</xref>
###xml 1189 1207 1164 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Kiema et al., 2006</xref>
A reasonable synthesis of the data in Fig. 1 (B and C) is that the membrane-distal region of the beta3 CT regulates integrin activation and does so by interacting with a cytoplasmic binding partner that cooperates with talin but binds to distinct sites. Molecules reported to bind to the membrane-distal conservative regions of beta3 CT include filamin, which binds to the T/S cluster, and beta3-endonexin, which binds to the NITY759 motif. Both have been suggested as regulators of integrin activation (filamin, a negative regulator, and beta3-endonexin, a positive regulator) (Eigenthaler et al., 1997; Kiema et al., 2006). To assess their roles in integrin activation, filamin A Ig-like domain 21 (FLNa21, the beta CT binding region) or beta3-endonexin was transfected or cotransfected together with talin-H into alphaIIbbeta3-CHO cells. Neither modulated talin-induced integrin activation or directly mediated integrin activation (Fig. 2, A and B; and Fig. S1 A, available at ), thus excluding them as the hypothetical coactivator of integrins. It should be noted that these data are not inconsistent with the proposed role of filamin A as a negative regulator of integrin activation (Kiema et al., 2006); suppressive effects of FLNa21 may not be evident in the presence of high talin-H levels.
###end p 11
###begin p 12
###xml 47 50 43 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 54 55 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 67 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kindlin-2 enhances talin-induced integrin &#945;<sub>IIb</sub>&#946;<sub>3</sub> activation.</bold>
###xml 83 84 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 144 147 130 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 151 152 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 186 189 165 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 193 194 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 485 486 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Kindlin-2 enhances talin-induced integrin alphaIIbbeta3 activation. EGFP-fused beta3 CT binding proteins were transiently transfected into alphaIIbbeta3-CHO cells. Their effects on alphaIIbbeta3 activation were evaluated by PAC1 binding (A and D) and expression levels were measured by Western blotting with anti-GFP antibody (B and E). Representative FACS histograms of PAC1 binding to talin-H and/or kindin-2 (kind-2) positive cells (C). Error bars (A and D) represent means +/- SD (n = 3). *, P < 0.05; **, P < 0.01 (versus vector).
###end p 12
###begin p 13
###xml 36 37 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 69 85 66 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Shi et al., 2007</xref>
###xml 174 191 171 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Wick et al., 1994</xref>
###xml 193 212 190 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Siegel et al., 2003</xref>
###xml 214 236 211 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Weinstein et al., 2003</xref>
###xml 238 256 235 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Ussar et al., 2006</xref>
###xml 389 404 386 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Tu et al., 2003</xref>
###xml 544 564 541 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Dowling et al., 2008</xref>
###xml 616 617 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 649 652 643 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 660 676 654 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Shi et al., 2007</xref>
###xml 702 705 692 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 709 710 696 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 823 839 810 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Shi et al., 2007</xref>
###xml 936 939 919 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 943 944 923 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 968 984 948 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 (C and D)</xref>
###xml 1040 1043 1016 1019 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 1047 1048 1020 1021 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1373 1381 1346 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 533 542 <span type="species:ncbi:7955">zebrafish</span>
Recently, we identified another beta3 CT binding protein, kindlin-2 (Shi et al., 2007), one of a three-member kindlin family that are characterized by bearing a FERM domain (Wick et al., 1994; Siegel et al., 2003; Weinstein et al., 2003; Ussar et al., 2006). Kindlin-2 contributes to the maturation of focal adhesions during cell shape changes through recruitment of migfilin and filamin (Tu et al., 2003). Targeted disruption of the kindlin-2 gene results in embryonic lethality in mice and causes multiple, severe abnormalities in zebrafish (Dowling et al., 2008). Distinct from talin, its interaction site on beta3 CT is not dependent on the NPLY747 motif (Shi et al., 2007). When expressed in alphaIIbbeta3-CHO cells, kindlin-2 induces statistically significant but very weak integrin activation compared with talin-H (Shi et al., 2007). To consider the role of kindlin-2 a coactivator with talin-H, both were transfected into alphaIIbbeta3-CHO cells. As shown in Fig. 2 (C and D), kindlin-2 dramatically enhanced talin-H-mediated alphaIIbbeta3 activation. This enhancement was not simply additive but represented functional synergism. We assessed the expression levels in different transfectants by Western blots to exclude that coexpression of kindlin-2 enhanced talin-H expression or vise-versa; expression of talin-H in single and double transfectants was similar (Fig. 2 E).
###end p 13
###begin p 14
###xml 72 73 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 236 244 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 260 261 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 361 364 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 425 426 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 449 452 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 459 462 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 551 559 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 630 631 618 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 744 752 732 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 801 802 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 853 854 835 836 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 914 915 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1007 1008 983 984 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1122 1123 1095 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1154 1157 1123 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 1161 1162 1127 1128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 175 180 <span type="species:ncbi:9606">human</span>
To further assess the role of kindlin-2 as a coactivator, GST-fused beta3 CT proteins were used to coprecipitate endogeneous kindlin-2 in lysates of CHO cells, platelets, and human umbilical vein endothelial cells (HUVECs). As shown in Fig. 3 A, wild-type beta3 CT interacts with kindlin-2 but GST alone did not, ascribing specificity to the interactions. The Y747A mutation abrogates talin-H but not kindin-2 binding to beta3 CT. In contrast, the S752P and Y759A mutations still support talin-H binding but dramatically reduce kindlin-2 association (Fig. 3 A). Thus, the binding requirements for talin-H and kindlin-2 on the beta3 CT are distinct and both bind to sites known to regulate integrin activation. Consistent with our observations (Fig. 2 A and Fig. S1 A), overexpression of FLNa21 or beta3-endonexin, two C-terminal binding proteins of beta3 CT, failed to suppress endogenous kindlin-2 binding to beta3 CT in CHO cells (Fig. S1 B), indicating a privileged interaction of kindlin-2 with the beta3 CT among these binding partners. As a point of emphasis, endogenous kindlin-2 coprecipitates with endogenous beta3 integrin subunit in both alphaIIbbeta3-CHO cells and HUVECs (Fig. S2, available at ).
###end p 14
###begin p 15
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">762</sup>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 120 128 120 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 179 182 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 184 187 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">762</sup>
###xml 249 250 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 255 263 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 500 503 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 510 513 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 586 594 569 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 677 678 657 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 762 778 742 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Liu et al., 1996</xref>
###xml 795 812 775 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Hers et al., 2000</xref>
###xml 843 844 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 848 849 821 822 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 859 862 828 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 866 867 832 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Peptides corresponding to Y747-T762 or a variant peptide containing the S752P and Y759A substitutions were synthesized (Fig. 3 B). When added as competitors (200 muM), wild-type Y747-T762 peptide inhibited kindlin-2 coprecipitation with the GST-beta3 CT (Fig. 3 C); the inhibition was approximately70% by densitometry. A lower concentration of peptide (100 muM) was still inhibitory but produced only 50% inhibition (unpublished data), suggesting a dose-dependent inhibitory effect. Introduction of S752P and Y759A mutations into the peptide totally abolished its competitive activity (Fig. 3 C). As control, both peptides had no effect on talin-H association with the GST-beta3 CT. It is noteworthy that introduction of similar peptides into endothelial cells (Liu et al., 1996) and platelets (Hers et al., 2000) significantly perturbed alphavbeta3 and alphaIIbbeta3 mediated responses, respectively. Thus, our results may provide a molecular explanation for these prior observations.
###end p 15
###begin p 16
###xml 54 55 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 59 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distinct binding sites for kindlin-2 and talin in &#946;<sub>3</sub> CT.</bold>
###xml 158 159 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 504 505 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 546 549 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 551 554 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">762</sup>
###xml 614 617 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 624 627 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 778 779 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Distinct binding sites for kindlin-2 and talin in beta3 CT. (A) Lysates of CHO cells, HUVECs, or out-dated platelets were incubated with GST or GST-fused beta3 CT bearing the indicated mutations in the presence of glutathione-Sepharose. After washing, the precipitates were analyzed by SDS-PAGE. The loading of the GST proteins was assessed by Coomassie blue staining. The associated kindlin-2 or talin-H was detected in Western blots with anti-kindlin-2 or anti-talin-H. (B) Amino acid sequences of beta3 CT C-terminal peptide corresponding to Y747-T762 and a mutant peptide with two loss-of-function mutations, S752P and Y759A. (C) The pull-down assay was performed in the presence of indicated peptides. The influence of these peptides on kindlin-2 or talin-H binding to beta3 CT was evaluated by SDS-PAGE and Western blotting.
###end p 16
###begin p 17
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 102 103 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 131 139 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">615</sup>
###xml 206 207 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 338 354 332 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Shi et al., 2007</xref>
###xml 418 419 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 478 486 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 629 630 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 706 707 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 713 714 701 702 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 745 746 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 763 771 748 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 822 825 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">615</sup>
###xml 944 945 926 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1168 1176 1150 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 1323 1326 1305 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">615</sup>
###xml 1745 1746 1727 1728 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1788 1789 1770 1771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1828 1831 1810 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 1852 1855 1834 1837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 1870 1871 1849 1850 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Like talin-H, kindlin-2 contains a FERM domain; its F2 subdomain is bisected by a PH domain, but its F3 (PTB) subdomain is intact (Fig. 4 A). Our previous experiments had shown that a QW615/AA mutation in F3, a site predicted by molecular modeling to be involved in beta CT engagement, did, in fact, disrupt its association with beta CT (Shi et al., 2007). We segmented kindlin-2 into several fragments, and their beta3 CT-binding capacities were evaluated by pull-down assays (Fig. 4 B). Deletion of the N-terminal region of kindlin-2, at N217 or at E345, the border of the PH domain insertion, ablated interaction with the beta3 CT. In addition, truncation of kindlin-2 to delete the second part of its F2 and F3 subdomains also disrupted beta3 CT interaction (Fig. 4 B). These deletions were more disruptive than the QW615 mutation. However, with deletion of PH domain alone, the mutant kindlin-2 still retained its capacity to bind the beta3 CT. The effects of these mutants on the coactivator activity of kindlin-2 were tested. When cotransfected with talin-H, deletion of either the N- or C-terminal region of kindlin-2 resulted in loss of coactivator activity (Fig. 4 C). The mutant with its PH domain deletion still retained some coactivator activity, although it was less potent than intact kindlin-2. Also, the QW615 mutant lacked coactivator activity, verifying that this site is involved not only in binding but also in coactivator function. We cannot exclude that some of these mutations may affect global folding of kindlin-2. However, it should be noted that FERM subdomains tend to fold independently into functional units. Thus, coactivator activity appears to depend on binding of kindlin-2 through both its N- and C-terminal F3 (PTB) domains. As to why the C-terminal F3 (PTB) of kindlin-2 recognizes the NITY759 rather than the NPLY747 region of beta3 CT will require high resolution structures.
###end p 17
###begin p 18
###xml 60 61 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 126 0 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Both the N and C terminus of kindlin-2 are required for &#946;<sub>3</sub> CT association and support of talin-induced integrin activation.</bold>
###xml 238 239 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 514 515 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 593 594 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 755 758 734 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 762 763 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1048 1049 1022 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Both the N and C terminus of kindlin-2 are required for beta3 CT association and support of talin-induced integrin activation. (A) Organization of predicated domains of kindlin-2 protein. The FERM domain is shown in yellow, in which the F2 subdomain is split by the PH domain. Deletion mutations from N terminus (DeltaN) or C terminus (DeltaC) are indicated. (B) The lysates of CHO cells transfected with EGFP-kindlin-2 with indicated mutations were used for pull-down assays. After incubating with GST fusion beta3 CT (wild-type) and glutathione-Sepharose, kindlin-2 protein bound to the beta3 CT was evaluated by SDS-PAGE and Western blotting using anti-GFP antibody. Kindlin-2 expression levels in lysates are also shown. (C) CHO cells expressing alphaIIbbeta3 were transiently transfected with empty EGFP vector or cDNA encoding the indicated proteins. Binding of PAC1 to the different transfectants was assessed by FACS and relative MFI of PAC1 binding were calculated as described in Materials and methods. Error bars represent means +/- SD (n = 3). **, P < 0.01 (versus talin-H).
###end p 18
###begin p 19
###xml 26 27 23 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 157 158 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 203 204 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 213 221 204 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 270 271 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 365 373 353 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 401 402 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 459 467 444 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 507 515 492 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 571 572 553 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 587 588 566 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
The colocalization of beta3 integrin and kindlin-2 was also tested in living cells. We found they dynamically associate with each other in HUVECs during beta3 integrin mediated cell spreading on the beta3 ligand (Fig. 5 A). At the early stage of spreading (30 min), beta3 (green) and kindlin-2 (red) colocalized in the lamellipodia at the edges of spreading cells (Fig. 5 A, top). Over time, both beta3 integrin and kindlin-2 moved into focal adhesion sites (Fig. 5 A, bottom, 60 min). The merged images in Fig. 5 A (right) verify the colocalization of kindlin-2 and beta3 integrin. beta3 integrin and talin also colocalize in spreading HUVECs with a similar pattern (Fig. S3 A, available at ). These observations place talin and kindlin-2 together, consistent with their cooperativity in function.
###end p 19
###begin p 20
###xml 34 35 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 63 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Endogenous kindlin-2 supports &#946;<sub>3</sub> integrin function in cells.</bold>
###xml 115 116 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 226 227 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 629 632 615 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 636 637 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 917 918 898 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1589 1592 1568 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">747</sup>
###xml 1725 1726 1701 1702 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1747 1750 1723 1726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">752</sup>
###xml 1760 1763 1736 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">759</sup>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 322 328 <span type="species:ncbi:9986">rabbit</span>
Endogenous kindlin-2 supports beta3 integrin function in cells. (A) Subcellular localizations of kindlin-2 and beta3 integrin. HUVECs spread on fibrinogen for 30 or 60 min were stained with the anti-kindlin-2 mAb and anti-beta3 subunit polyclonal antibody followed by AlexaFluor 568 anti-mouse IgG and AlexaFluor 488 anti-rabbit IgG. Bar, 10 mum. (B) RNAi suppression of kindlin-2 expression in CHO cells. Expression of kindlin-2 in parental CHO cells (non-T), kindlin-2 siRNA (SiKind-2), or control RNA (SiControl) transfectants was analyzed by Western blotting with kindlin-2 or actin antibodies. (C) CHO cells expressing alphaIIbbeta3 were transiently transfected with vector or talin-H, together with control RNAs (SiControl) or siRNAs targeting kindlin-2 (SiKind-2). The binding of PAC1 to the different transfectants was assessed by FACS and MFI of PAC1 binding was calculated. The error bars are means +/- SD (n = 3). (D) RNAi suppression of kindlin-2 expression in HUVECs. (E and F) Non-transfected (Non-T) or HUVECs transfected with control RNAs (SiControl) or targeted siRNAs for Kindlin-2 (SiKind-2) were used in adhesion assays (E) or migration assays (F). The adherent or migrated cells were fixed, stained, and counted (10x objective). The error bars are means +/- SD of three independent experiments. (G) HUVECs transfected with control RNAs (SiControl) or targeted siRNAs for kindlin-2 (SiKind-2) were stimulated with PMA, and adhesion to fibrinogen was measured. (H) Kindlin-2 as an integrin coactivator. Integrin activation depends on interaction of talin-H with the NPLY747 motif and the membrane-proximal clasping region. Kindlin-2 facilitates activation by associating with the C-terminal regions of beta3 CT, involving the TS752T and NITY759 motifs.
###end p 20
###begin p 21
###xml 50 51 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 247 250 240 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 254 255 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 424 432 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 660 663 646 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 667 668 650 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 700 703 679 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 707 708 683 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 739 760 715 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Tadokoro et al., 2003</xref>
###xml 921 929 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 999 1002 971 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 1006 1007 975 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
To determine if endogenous kindlin-2 supports beta3 integrin function, RNA-mediated interference experiments were performed. Small interfering RNAs targeting kindlin-2 (siKind-2) or irrelevant RNAs as control (siControl) were introduced into alphaIIbbeta3-CHO cells, and kindlin-2 expression levels were analyzed by Western blot. Transfection of siKind-2 but not siControl effectively inhibited the expression of kindlin-2 (Fig. 5 B). The decrease in kindlin-2 protein expression was 70% by densitometry. Neither the siKind-2 nor the siControl changed actin expression, establishing selectivity of the siKind-2 on kindlin-2 expression. Talin-H can induce alphaIIbbeta3 activation in transfected alphaIIbbeta3-CHO cells as shown by others (Tadokoro et al., 2003) and in this study. However, talin-H-mediated integrin activation was significantly blunted when kindlin-2 levels were reduced with siKind-2 but not siControl (Fig. 5 C), indicating that endogenous kindlin-2 supports talin-H-induced alphaIIbbeta3 activation in these cells.
###end p 21
###begin p 22
###xml 125 126 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 130 131 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 201 218 194 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Plow et al., 2000</xref>
###xml 286 294 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 379 380 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 426 434 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 536 544 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 653 654 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 658 659 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 672 691 655 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Byzova et al., 2000</xref>
###xml 907 923 890 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Shi et al., 2007</xref>
###xml 1148 1173 1131 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Huttenlocher et al., 1996</xref>
###xml 1175 1195 1158 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Palecek et al., 1997</xref>
###xml 1302 1310 1285 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 G</xref>
###xml 1335 1336 1314 1315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1340 1341 1316 1317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1463 1464 1436 1437 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
We also tested the function of kindlin-2 knock-down in cells that express an integrin naturally. HUVECs express and use alphavbeta3 to mediate cell adhesion and migration on fibrinogen or vitronectin (Plow et al., 2000). Endogenous kindlin-2 could be knocked down in HUVEC using siRNA (Fig. 5 D), and the deficiency of kindlin-2 dramatically suppressed HUVEC adhesion on the beta3 integrin ligands, fibrinogen or vitronectin (Fig. 5 E). In addition, knockdown of kindlin-2 in HUVECs significantly inhibited VEGF-induced cell migration (Fig. 5 F). Under the conditions used, VEGF induced HUVEC migration on fibrinogen or vitronectin is dependent on alphavbeta3 activation (Byzova et al., 2000), and there is little cell proliferation (< 50% increase) in serum-free medium (unpublished data). Interestingly, we previously found that overexpression of kindlin-2 also inhibited migration for some cancer cells (Shi et al., 2007). These two distinct observations suggest that the supportive role of kindlin-2 in integrin activation might be cell type and/or integrin specific or depends on specific experimental conditions such as ligand concentration (Huttenlocher et al., 1996; Palecek et al., 1997). Furthermore, knocking down kindlin-2 significantly suppressed PMA-induced HUVEC adhesion on fibrinogen (Fig. 5 G), which is also an alphavbeta3 activation-dependent process. In concert, these results suggest that kindlin-2 plays an important role in supporting beta3 integrin functions dependent on activation.
###end p 22
###begin p 23
###xml 176 184 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 294 295 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 379 385 376 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 440 441 434 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 566 581 560 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, C and D</xref>
###xml 720 735 714 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, B and C</xref>
Nonetheless, kindlin-2 is unlikely to be a direct activator of integrin; overexpression of kindlin-2 alone only had a mild effect on integrin activation compared with talin-H (Fig. 2 D). Even though kindlin-2 also bears a FERM-like domain as does talin-H, the binding sites of kindlin-2 on beta3 CT are solely localized at its C terminus beyond of the talin-H recognition sites (Fig. 3), which allows kindlin-2 and talin to bind to the beta3 CT together. This possibility has been established by the synergistic role of talin-H and kindlin-2 in integrin activation (Fig. 2, C and D) and further verified by the finding that knockdown of endogenous kindlin-2 significantly suppressed talin-H-induced integrin activation (Fig. 5, B and C).
###end p 23
###begin p 24
###xml 80 81 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 180 195 177 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Ma et al., 2007</xref>
###xml 241 249 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 H</xref>
###xml 301 302 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 560 561 551 552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 625 626 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 679 680 664 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 791 792 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 924 929 <span type="species:ncbi:9606">human</span>
In summary, we found that kindlin-2 is a coactivator of talin in supporting beta3 integrin activation. As such, kindlin-2 is the first of the postulated coactivators of integrins (Ma et al., 2007) to be identified. Our data support a model (Fig. 5 H) in which kindlin-2 binds to the C terminus of beta3 CT beyond of the talin-binding sites. Functionally, kindlin-2 synergistically enhances talin-induced integrin activation. Kindlin-2 may associate with membrane via its PH domain, an interaction commonly associated with these domains, and interacts with beta3 CT via its N terminus and C-terminal PTB domain. Anchoring beta3 CT by kindlin-2 could reduce the flexibility of beta3 CT in the cytosol, positioning it more favorably for interaction with talin and might also displace other beta3 CT binding partners. Due to the variable expression of kindlin-2 in different tissues and cells, e.g., its levels are quite low in human platelets versus HUVECs (Fig. S3 B), one must consider the possibilities that kindlin-2 may exert a "catalytic" effect on integrin activation, where one molecule coactivates multiple integrins, or whether this coactivator activity of kindlin-2 is shared or compensated by other kindlin family members or by other integrin binding partners.
###end p 24
###begin title 25
Materials and methods
###end title 25
###begin title 26
Plasmid construction and mutagenesis
###end title 26
###begin p 27
###xml 23 26 19 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 35 36 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 190 191 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 357 358 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 397 398 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 489 511 473 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Sheffield et al., 1999</xref>
###xml 529 530 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 690 691 668 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
###xml 680 685 <span type="species:ncbi:9606">human</span>
The cDNA of human alphaIIb and beta3 subunits were inserted into the mammalian expression vector pcDNA3.1 (Invitrogen). The mouse talin head domain (1-429 amino acids), human kindlin-2, beta3-endonexin, and filamin A Ig-like domain 21 (2235-2330 amino acids) were cloned into pEGFP vectors (Clontech Laboratories, Inc.). For the construct of GST-tagged beta3 cytoplasmic tail, the fragment of beta3 tail (716-762 amino acids) was amplified by PCR and inserted into pGST-parallel-1 vector (Sheffield et al., 1999). The PSGL-1/beta3 chimera was constructed in pcDNA3.1 vector in which N terminus (1-91 amino acids) of human PSGL-1 was fused onto C terminus (468-762 amino acids) of human beta3 subunit. All the indicated mutations were introduced into the respective constructs using QuikChange site-directed mutagenesis kit (Stratagene) and confirmed by gene sequencing.
###end p 27
###begin title 28
###xml 14 17 10 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 21 22 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Integrin alphaIIbbeta3 activation assay
###end title 28
###begin p 29
###xml 18 21 14 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 25 26 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 111 114 100 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 118 119 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 172 173 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 191 194 170 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 198 199 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 220 221 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 286 289 255 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 316 319 285 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">995</sup>
###xml 493 508 462 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Ma et al., 2006</xref>
###xml 563 566 528 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 570 571 532 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 654 657 612 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 661 662 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 875 878 826 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 882 883 830 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
The integrin alphaIIbbeta3 activation was evaluated with PAC1, a mAb which specifically recognizes active alphaIIbbeta3. For testing how the membrane-distal regions of beta3 CT regulate alphaIIbbeta3 activation, the beta3 subunit bearing different mutations was cotransfected with alphaIIb subunit, with or without R995D mutation, into CHO-K1 cells using Lipofectamine 2000 (Invitrogen). 24 h after transfection, the cells were collected and PAC1 binding was assessed as described previously (Ma et al., 2006). In brief, PAC1 binding was first normalized by alphaIIbbeta3 expression level on the cell surfaces measured by mAb 2G12, which is against alphaIIbbeta3 complex independent of activation status. The values of normalized PAC1 binding on different transfectants were compared to determine relative integrin activation, defining the basal activation of wild-type alphaIIbbeta3 as 1.0.
###end p 29
###begin p 30
###xml 54 55 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 81 84 74 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 88 89 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 252 255 238 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 259 260 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 267 270 246 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 274 275 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
For determining the regulatory roles of different beta3-binding partners in alphaIIbbeta3 activation, individual EGFP-fused candidate binding partners or combinations of binding partners were transfected into CHO cells stably expressing wild-type alphaIIbbeta3 (alphaIIbbeta3-CHO). PAC1 binding to the different transfectants was analyzed by flow cytometry, gating only on the EGFP-positive cells. Mean fluorescence intensities (MFI) of PAC1 binding were normalized based on the basal level of PAC1 binding to cells transfected with the EGFP vector alone to obtain relative MFI values.
###end p 30
###begin title 31
Cell spreading
###end title 31
###begin p 32
###xml 41 42 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 63 64 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 93 96 83 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 100 101 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 312 337 299 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">McEver and Cummings, 1997</xref>
###xml 758 762 <span type="species:ncbi:9925">goat</span>
###xml 768 773 <span type="species:ncbi:10090">mouse</span>
Monomeric PSGL-1 (mPSGL-1) or PSGL-1/beta3 chimera (PSGL1N-beta3C) was transfected into alphaIIbbeta3-CHO cells. The mPSGL-1 was obtained by substitution of a single extracellular cysteine at the junction of the transmembrane domain with A to disturb the disulfide bond essential for PSGL-1 homodimer formation (McEver and Cummings, 1997). The transiently transfected cells were allowed to adhere and spread on immobilized fibrinogen in Laboratory-Tek II chambers (Nalge Nunc International). After incubation at 37degreesC for 2 h, the chambers were washed three times with PBS and the adherent cells were fixed by 4% paraformaldehyde. To identify PSGL-1-expressing cells, the fixed cells were stained by anti-PSGL-1 mAb, KPL-1 (BD Biosciences), followed by goat anti-mouse IgG conjugated with AlexaFluor 488 (Invitrogen). As controls, nontransfected cells with the same treatment were included in each experiment and always showed no PSGL-1 staining. The positively stained (green) cells were observed using a fluorescence microscope (model DMR; Leica) with a 10X objective and recorded with a cooled CCD camera (Retiga Exi; Q-Imaging). Data were analyzed with ImagePro Plus Capture and Analysis software (Media Cybernetics).
###end p 32
###begin title 33
GST pull-down assays and Western blotting
###end title 33
###begin p 34
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 521 522 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 792 807 786 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Tu et al., 2003</xref>
###xml 862 867 <span type="species:ncbi:9606">human</span>
Glutathione-S-transferase (GST) fusion proteins were expressed in Rosetta2 (DE3) cells, purified by glutathione-affinity chromatography using a GSTPrepFF column (GE Healthcare), and quantified by spectrophotometry using calculated extinction coefficients and Coomassie blue staining of SDS-PAGE. The cell lysates of transfected CHO cells, out-dated platelets, and HUVECs were prepared in the lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 1% Triton X-100) containing protease inhibitors and centrifuged at 15,000 g for 12 min. For the GST pull-down assays, glutathione-Sepharose 4B (GE Healthcare) and the indicated GST fusion proteins were added to the aliquots of lysate supernatants and incubated at 4degreesC for 8 h. The antibodies used for Western blotting were anti-kindlin-2 (Tu et al., 2003), anti-GFP (Santa Cruz Biotechnology, Inc.), and anti-human talin (Chemicon International).
###end p 34
###begin title 35
Immunofluorescence and confocal microscopy
###end title 35
###begin p 36
###xml 50 51 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 310 311 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 369 374 <span type="species:ncbi:10090">mouse</span>
###xml 403 409 <span type="species:ncbi:9986">rabbit</span>
To observe the distributions of kindlin-2 and beta3 integrins, HUVECs were allowed to spread on immobilized fibrinogen at 37degreesC for 30 min or 60 min. The spread cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and stained with mAb anti-kindlin-2 and polyclonal Ab anti-beta3 (Chemicon International) followed by AlexaFluor 568 anti-mouse IgG and AlexaFluor 488 anti-rabbit IgG (Invitrogen). The images were recorded by a confocal microscope with a 63X objective (Leica).
###end p 36
###begin title 37
RNA interference
###end title 37
###begin p 38
To knock down endogenous kindlin-2, irrelevant control RNAs or designed siRNAs targeting kindlin-2 (from Dharmacon) were transfected to CHO cells using Lipofectamine 2000 (based on the protocol for siRNA transfection from Invitrogen) and HUVECs using targetfect-HUVEC (Targeting Systems) according to the manufacturers' protocols. The extent of suppression and specificity for kindlin-2 were evaluated by Western blotting with anti-kindlin-2 and actin antibodies as controls.
###end p 38
###begin title 39
HUVEC adhesion and migration
###end title 39
###begin p 40
###xml 499 500 487 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 504 505 489 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 612 631 597 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Byzova et al., 2000</xref>
###xml 1049 1050 1027 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1000 1005 <span type="species:ncbi:9606">human</span>
For cell adhesion assays, the nontransfected or transfected HUVECs, with targeting or control siRNAs, were incubated with the immobilized integrin ligand, fibrinogen (20 mug/ml for coating) or vitronectin (5 mug/ml for coating), for 30 min at 37degreesC. After washing, the adhered cells were fixed by 70% methanol and stained with 1% totuidine blue, and the cell number was counted under a microscope in several randomly selected fields. To test the effect of kindlin-2 deficiency on integrin alphavbeta3 activation, we stimulated transfected HUVECs with PMA and measured cell adhesion as previously described (Byzova et al., 2000). The PMA-induced cell adhesion was calculated as the increase based on the background without PMA treatment. Cell migration was performed in Transwell plates (8 mum pore size). In brief, the HUVEC suspensions were added to the upper chamber, which was precoated with fibrinogen or vitronectin and allowed to migrate for 8-12 h in the presence of 20 ng/ml recombinant human VEGF (R&D Systems) at 37degreesC in a 5% CO2 humidified incubator. After migration, the cells on the upper surface of the filter were removed; and the migrated cells on the bottom surface of the filter were fixed with methanol, stained with 1% totuidine blue, and quantified by performing microscopic cell counts.
###end p 40
###begin title 41
Statistic analysis
###end title 41
###begin p 42
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Quantitative data were compared using a two-tailed t test. P values to determine statistical significance are indicated in the text. For the experiments to observe adherent or migrated cells, 10-20 fields or confocal cell images were randomly taken in at least three independent experiments.
###end p 42
###begin title 43
Online supplemental material
###end title 43
###begin p 44
###xml 42 43 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 89 92 82 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 96 97 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 117 118 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 193 194 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 275 276 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 334 339 <span type="species:ncbi:9606">human</span>
Fig. S1 shows that neither FLNa21 nor beta3-endonexin has direct effect on integrin alphaIIbbeta3 activation and beta3 CT/kindlin-2 association. Fig. S2 shows the interaction of endogenous beta3 integrin subunit and kindlin-2. Fig. S3 shows the dynamic colocalization of beta3 integrin and talin in HUVECs and kindlin-2 expression in human platelets. Online supplemental material is available at .
###end p 44
###begin title 45
Supplemental Material
###end title 45
###begin title 46
[Supplemental Material Index]
###end title 46
###begin p 47
We thank Ka Chen, Zhen Xu, Kamila Bledzka, and Mitali Das for technical assistance.
###end p 47
###begin p 48
This work was supported by NIH grants P01HL073311 (to E.F. Plow and J. Qin), GM62823 (to J. Qin), and GM65188 to C. Wu.
###end p 48

